Small Company Offering and Sale of Securities Without Registration (d)
2020年11月25日 - 6:40AM
Edgar (US Regulatory)
o
NoneEntity Type | 0001321834 | None Akers Biosciences Inc |
x
Corporation
o
Limited Partnership
o
Limited Liability Company
o
General Partnership
o
Business Trust
o
Other |
Name of Issuer |
Akers Biosciences, Inc. |
Jurisdiction of Incorporation/Organization |
NEW JERSEY |
|
Year of Incorporation/Organization |
|
x
| Over Five Years Ago |
|
o
| Within Last Five Years (Specify Year) | |
|
o
| Yet to Be Formed | |
2. Principal Place of Business and Contact Information |
Name of Issuer | |
Akers Biosciences, Inc. | |
Street Address 1 | Street Address 2 |
201 GROVE ROAD | |
City | State/Province/Country | ZIP/Postal Code | Phone No. of Issuer |
THOROFARE | NEW JERSEY | 08086 | (856) 848-8698 |
Last Name | First Name | Middle Name |
Benson | Stuart | |
Street Address 1 | Street Address 2 |
201 Grove Road | |
City | State/Province/Country | ZIP/Postal Code |
Thorofare | NEW JERSEY | 08086 |
Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Chief Financial Officer |
Last Name | First Name | Middle Name |
Schreiber | Christopher | C. |
Street Address 1 | Street Address 2 |
201 Grove Road | |
City | State/Province/Country | ZIP/Postal Code |
Thorofare | NEW JERSEY | 08086 |
Relationship: |
x
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| President and Chief Executive Officer |
Last Name | First Name | Middle Name |
Silverman | Joshua | |
Street Address 1 | Street Address 2 |
201 Grove Road | |
City | State/Province/Country | ZIP/Postal Code |
Thorofare | NEW JERSEY | 08086 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Chairman of the Board of Directors |
Last Name | First Name | Middle Name |
White | Bill | J. |
Street Address 1 | Street Address 2 |
201 Grove Road | |
City | State/Province/Country | ZIP/Postal Code |
Thorofare | NEW JERSEY | 08086 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| |
Last Name | First Name | Middle Name |
Schroeder | Robert | C. |
Street Address 1 | Street Address 2 |
201 Grove Road | |
City | State/Province/Country | ZIP/Postal Code |
Thorofare | NEW JERSEY | 08086 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| |
o
| Agriculture | | Health Care |
o
| Retailing |
| Banking & Financial Services | |
o
| Biotechnology |
o
| Restaurants |
|
o
| Commercial Banking | |
o
| Health Insurance | | Technology |
|
o
| Insurance | |
o
| Hospitals & Physicians | |
o
| Computers |
|
o
| Investing | |
o
| Pharmaceuticals | |
o
| Telecommunications |
|
o
| Investment Banking | |
x
| Other Health Care | |
o
| Other Technology |
|
o
| Pooled Investment Fund
| | | | | Travel |
|
o
| Other Banking & Financial Services |
o
| Manufacturing | |
o
| Airlines & Airports |
| Real Estate | |
o
| Lodging & Conventions |
|
o
| Commercial | |
o
| Tourism & Travel Services |
|
o
| Construction | |
o
| Other Travel |
|
o
| REITS & Finance |
o
| Other |
|
o
| Residential | |
|
o
| Other Real Estate | |
o
| Business Services | |
| Energy | |
|
o
| Coal Mining | |
|
o
| Electric Utilities | |
|
o
| Energy Conservation | |
|
o
| Environmental Services | |
|
o
| Oil & Gas | |
|
o
| Other Energy | |
Revenue Range | Aggregate Net Asset Value Range |
o
| No Revenues |
o
| No Aggregate Net Asset Value |
o
| $1 - $1,000,000 |
o
| $1 - $5,000,000 |
o
| $1,000,001 - $5,000,000 |
o
| $5,000,001 - $25,000,000 |
o
| $5,000,001 - $25,000,000 |
o
| $25,000,001 - $50,000,000 |
o
| $25,000,001 - $100,000,000 |
o
| $50,000,001 - $100,000,000 |
o
| Over $100,000,000 |
o
| Over $100,000,000 |
x
| Decline to Disclose |
o
| Decline to Disclose |
o
| Not Applicable |
o
| Not Applicable |
6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) |
o
| Rule 504(b)(1) (not (i), (ii) or (iii)) |
o
| Rule 505 |
o
| Rule 504 (b)(1)(i) |
x
| Rule 506(b) |
o
| Rule 504 (b)(1)(ii) |
o
| Rule 506(c) |
o
| Rule 504 (b)(1)(iii) |
o
| Securities Act Section 4(a)(5) |
|
o
| Investment Company Act Section 3(c) |
x
| New Notice | Date of First Sale | 2020-11-11 |
o
| First Sale Yet to Occur |
Does the Issuer intend this offering to last more than one year? |
o
| Yes |
x
| No |
9. Type(s) of Securities Offered (select all that apply) |
o
| Pooled Investment Fund Interests |
x
| Equity |
o
| Tenant-in-Common Securities |
o
| Debt |
o
| Mineral Property Securities |
o
| Option, Warrant or Other Right to Acquire Another Security |
x
| Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security |
o
| Other (describe) |
| |
10. Business Combination Transaction |
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? |
o
| Yes |
x
| No |
|
Clarification of Response (if Necessary) | |
|
Minimum investment accepted from any outside investor | $ 0 USD |
Recipient | Recipient CRD Number |
o
| None |
Katalyst Securities LLC | 112494 |
(Associated) Broker or Dealer |
x
| None | (Associated) Broker or Dealer CRD Number |
x
| None |
| |
Street Address 1 | Street Address 2 |
630 THIRD AVENUE | 5TH FLOOR |
City | State/Province/Country | ZIP/Postal Code |
NEW YORK | NEW YORK | 10017 |
State(s) of Solicitation |
o
| All States |
o
| Foreign/Non-US |
CALIFORNIA CONNECTICUT FLORIDA GEORGIA ILLINOIS INDIANA IOWA MARYLAND MASSACHUSETTS MICHIGAN NEW JERSEY NEW YORK OHIO PENNSYLVANIA SOUTH DAKOTA |
13. Offering and Sales Amounts |
Total Offering Amount | $ 18067000 USD |
o
Indefinite |
Total Amount Sold | $ 18067000 USD | |
Total Remaining to be Sold | $ 0 USD |
o
Indefinite |
|
Clarification of Response (if Necessary) |
Represents 9,765,933 shares of common stock or pre-funded warrants and warrants to purchase 9,765,933 shares of common stock at $2.06 per share. |
o
| Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering
| |
| Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: | 56 |
15. Sales Commissions & Finders’ Fees Expenses |
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
|
Sales Commissions | $ 1174355 USD |
o
| Estimate |
Finders' Fees | $ 0 USD |
o
| Estimate |
|
Clarification of Response (if Necessary) |
In addition to the sales commission noted above, the placement agent also received a warrant to purchase 390,368 shares of Issuer's common stock at $1.85 per share. |
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
|
| $ 0 USD |
o
Akers Biosciences (NASDAQ:AKER) 過去 株価チャート から 6 2024 まで 7 2024
Akers Biosciences (NASDAQ:AKER) 過去 株価チャート から 7 2023 まで 7 2024
Real-Time news about Akers Biosciences Inc (ナスダック市場): 0 recent articles
その他のAkers Biosciences, Inc.ニュース記事
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
|